002390SZSE

Announcement on the Resolution of the 2025 Shareholders' Meeting

✨ AI Summary

This announcement details the resolutions passed at the 2025 Shareholders' Meeting of Guizhou Xinbang Pharmaceutical Co., Ltd. The meeting was legally convened and held, with all proposed items passing. Key decisions included approving the 2025 Board of Directors' Work Report, the 2025 Profit Distribution Proposal, and the 2025 Annual Report.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 002390 Stock Abbreviation: Xinbang Pharmaceutical Announcement No.: 2026-016

Guizhou Xinbang Pharmaceutical Co., Ltd. Announcement on the Resolution of the 2025 Shareholders' Meeting

The Company and all members of the Board of Directors guarantee the content of the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or material omissions.

Special Notes

  1. This shareholders' meeting did not involve the addition, rejection, or amendment of proposals.
  2. This shareholders' meeting does not involve the change of resolutions previously passed by shareholders' meetings.

I. Convening of the Meeting

  1. Notice of the Meeting Guizhou Xinbang Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") published the "Announcement on Convening the 2025 Shareholders' Meeting" (Announcement No.: 2026-013) in the China Securities Journal, Securities Times, and on the Juchao Information Network (http://www.cninfo.com.cn) on April 21, 2026.
  2. Convenor: The Ninth Board of Directors of the Company
  3. Chairman: Ms. An Ji, Chairperson
  4. Meeting Time: 2:00 PM on May 12, 2026
  5. Meeting Location: Conference Room 15, Ke Kai No. 1, Ke Kai No. 1, Xintian Avenue North Section, Wudang District, Guiyang City, Guizhou Province
  6. Equity Registration Date: May 6, 2026
  7. Method of Convening: A combination of on-site written voting and online voting.
  8. The convening and holding of this shareholders' meeting comply with the provisions of the Company Law, Securities Law, Shenzhen Stock Exchange Stock Listing Rules, and the Articles of Association, and the meeting is legal and valid.

II. Attendance at the Meeting (I) Overall Attendance at the Meeting A total of 314 shareholders and their authorized representatives attended this meeting, representing 496,416,812 shares with voting rights, accounting for 26.1767% of the Company's total shares with voting rights. The breakdown is as follows:

  1. On-site Meeting Attendance A total of 6 shareholders and their authorized representatives attended the on-site meeting, representing 478,278,473 shares with voting rights, accounting for 25.2203% of the Company's total shares with voting rights.
  2. Online Voting A total of 308 shareholders voted through the Shenzhen Stock Exchange trading system and the internet voting system, representing 18,138,339 shares with voting rights, accounting for 0.9565% of the Company's total shares with voting rights. (II) Attendance of Small and Medium Investors (shareholders holding more than 5% of the listed company's shares individually or collectively, and directors, supervisors, and senior management of the listed company other than other shareholders) A total of 308 small and medium investors and their authorized representatives attended this meeting, representing 18,138,339 shares with voting rights, accounting for 0.9565% of the Company's total shares with voting rights. The breakdown is as follows:
  3. On-site Meeting Attendance A total of 0 small and medium investors and their authorized representatives attended the on-site meeting, representing 0 shares with voting rights, accounting for 0.0000% of the Company's total shares with voting rights.
  4. Online Voting A total of 308 small and medium investors voted through the Shenzhen Stock Exchange trading system and the internet voting system, representing 18,138,339 shares with voting rights, accounting for 0.9565% of the Company's total shares with voting rights. (III) The Company's directors and senior management attended the meeting, and the lawyer engaged by the Company to witness the meeting attended the meeting.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.